Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
We welcome Bill to the Zoetis Board.
He brings significant expertise and relevant industry and operational experience to Zoetis and I am confident he will provide valuable insight and perspectives as we continue to enhance our position as the world leader in animal health.
As the industry leader in the animal health market, Zoetis is an exceptional company with a diverse product portfolio and great long-term value creation potential.
Login to comment.